XWELL Q3 revenue $7.5M; airport spa revenue up 39% YoY; non-cash impairment $6.8M

XWELL, Inc.

2023-Q3 EPS reported -$5.07 vs consensus -$0.82 ▼ miss (-521.3%)

Total revenue $7.5M, down from $10.7M in Q3 2022; XpresSpa revenue grew ~39% YoY to $5.0M.
Non-cash goodwill & intangible impairment of $6.8M, primarily on HyperPointe and Treat assets.
GAAP loss from operations $10.5M; non-GAAP loss (excl. impairment) $3.7M vs. $7.1M loss in Q3 2022.
Naples Wax Center acquired for ~$1.5M in mid-September; plan to grow by 8–10 locations in 12-18 months.
CDC renewed TGS contract for ~$16M; expanded to test for 30+ priority pathogens at four U.S. airports.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

XWELL, Inc. reported financial results for the third quarter ended September 30, 2023.

Period: the third quarter ended September 30, 2023
Result: reported results

Exact text from the filing

XWELL, Inc., dated November 14, 2023, announcing certain operating results for the fiscal quarter ended September 30, 2023.

View on SEC.gov

38 earnings releases filed in the last 30 days. Browse all earnings releases →

XWELL, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-118179

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.